A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

Florence Atrafi; HJM Groen; LA Byers; E Garralda; Martijn Lolkema; RS Sangha; S Viteri; YK Chae; DR Camidge; NY Gabrail; BB Hu; T Tian; S Nuthalapati; E Hoening; L He; P Komarnitsky; A Calles

doi:10.1158/1078-0432.Ccr-18-2014

A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

Florence Atrafi, HJM Groen, LA Byers, E Garralda, Martijn Lolkema, RS Sangha, S Viteri, YK Chae, DR Camidge, NY Gabrail, BB Hu, T Tian, S Nuthalapati, E Hoening, L He, P Komarnitsky, A Calles

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

38 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	496-505
Number of pages	10
Journal	Clinical Cancer Research
Volume	25
Issue number	2
DOIs	https://doi.org/10.1158/1078-0432.Ccr-18-2014
Publication status	Published - 2019

Research programs

EMC MM-03-86-08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.Ccr-18-2014

http://hdl.handle.net/1765/114769

Cite this

Atrafi, F., Groen, HJM., Byers, LA., Garralda, E., Lolkema, M., Sangha, RS., Viteri, S., Chae, YK., Camidge, DR., Gabrail, NY., Hu, BB., Tian, T., Nuthalapati, S., Hoening, E., He, L., Komarnitsky, P., & Calles, A. (2019). A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors. Clinical Cancer Research, 25(2), 496-505. https://doi.org/10.1158/1078-0432.Ccr-18-2014

@article{132f32b6fafe4c18b05121115721997b,

title = "A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors",

author = "Florence Atrafi and HJM Groen and LA Byers and E Garralda and Martijn Lolkema and RS Sangha and S Viteri and YK Chae and DR Camidge and NY Gabrail and BB Hu and T Tian and S Nuthalapati and E Hoening and L He and P Komarnitsky and A Calles",

year = "2019",

doi = "10.1158/1078-0432.Ccr-18-2014",

language = "Undefined/Unknown",

volume = "25",

pages = "496--505",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "2",

}

Atrafi, F, Groen, HJM, Byers, LA, Garralda, E, Lolkema, M, Sangha, RS, Viteri, S, Chae, YK, Camidge, DR, Gabrail, NY, Hu, BB, Tian, T, Nuthalapati, S, Hoening, E, He, L, Komarnitsky, P & Calles, A 2019, 'A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors', Clinical Cancer Research, vol. 25, no. 2, pp. 496-505. https://doi.org/10.1158/1078-0432.Ccr-18-2014

TY - JOUR

T1 - A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

AU - Atrafi, Florence

AU - Groen, HJM

AU - Byers, LA

AU - Garralda, E

AU - Lolkema, Martijn

AU - Sangha, RS

AU - Viteri, S

AU - Chae, YK

AU - Camidge, DR

AU - Gabrail, NY

AU - Hu, BB

AU - Tian, T

AU - Nuthalapati, S

AU - Hoening, E

AU - He, L

AU - Komarnitsky, P

AU - Calles, A

PY - 2019

Y1 - 2019

U2 - 10.1158/1078-0432.Ccr-18-2014

DO - 10.1158/1078-0432.Ccr-18-2014

M3 - Article

SN - 1078-0432

VL - 25

SP - 496

EP - 505

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 2

ER -